Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Surgical Oncology|October 11, 2012
Parathyroid carcinoma: the importance of high clinical suspicion for a correct managementGabriele Ricci, Marco Assenza, Marco Barreca, et al.Methods in Molecular Biology (Clifton, N.J.)|September 30, 2025
Deciphering the Tumor Microenvironment Composition Using Bulk Transcriptomics: A Guide to Recent Advances and Open ChallengesSotiris Ouzounis, Donya Zojaji, Sandra García-Mulero, et al.NPJ Precision Oncology|October 25, 2024
Development and validation of a gene expression-based Breast Cancer Purity ScoreMarco Barreca, Matteo Dugo, Barbara Galbardi, et al.Annals of Surgery|December 24, 2005
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective studyMauro Rossi, Marco Barreca, Nicola de Bortoli, et al.British Journal of Cancer|November 7, 2023
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapyLuca Licata, Marco Barreca, Barbara Galbardi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
Radionuclide gastroesophageal motor studiesGiuliano Mariani, Giuseppe Boni, Marco Barreca, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Radionuclide evaluation of the lower gastrointestinal tractGiuliano Mariani, Ernest K J Pauwels, Abedallatif AlSharif, et al.Nature Communications|March 4, 2025
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapiesMaurizio Callari, Matteo Dugo, Marco Barreca, et al.European Journal of Cancer (Oxford, England : 1990)|November 1, 2023
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment responseCarlo Bosi, Áron Bartha, Barbara Galbardi, et al.NPJ Precision Oncology|June 15, 2026
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapyGiulia Notini, Barbara Galbardi, Giulia Viale, et al.Pageof 2